NCCM
DGX icon

Nine Chapters Capital Management’s Quest Diagnostics DGX Stock Holding History

Nine Chapters Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-32,900
Closed -$2.53M – 1001
2015
Q1 		$2.53M Buy
+32,900
New +$2.36M 0.21% 118
2014
Q3 		– Sell
-15,500
Closed -$910K – 1027
2014
Q2 		$910K Buy
+15,500
New +$908K 0.07% 369
2014
Q1 		– Sell
-58,000
Closed -$3.1M – 840
2013
Q4 		$3.1M Buy
+58,000
New +$3.44M 0.31% 71

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nine Chapters Capital Management's DGX Position: Q2 2015 in Review

Nine Chapters Capital Management sold out of Quest Diagnostics (DGX) in Q2 2015, closing a stake of 32,900 shares — an estimated $2.53M sold.

Nine Chapters Capital Management first reported a position in DGX in Q4 2013 and held it in 3 quarters. The position peaked at $3.1M in Q4 2013. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

  • Nine Chapters Capital Management reported no remaining Quest Diagnostics position as of Q2 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 32,900 Quest Diagnostics shares in Q2 2015, an estimated $2.53M.
  • Nine Chapters Capital Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 3 quarters.
  • Nine Chapters Capital Management's Quest Diagnostics position peaked at $3.1M in Q4 2013.
  • 542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Nine Chapters Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.